Replies to post #6968 on Kitov Pharmaceuticals Hldgs L Sponsored ADR (KTOV)

[tykundegex]

I did like the premise of this company at first and I still hold shares (way underwater, including warrants). Their team has deep knowledge of the FDA processes, and approach seemed to be finding undervalued drugs due to trials that failed for reasons that have less to do with true efficacy (underpowered, unclear endpoints, poor candidate targeting), or finding complementary compounds.. I thought held promise.

For me it was the farcical Consensi deal that turned me off this company. Coeptis is a bogus partner.. a brand new company run by people with zero experience selling drugs. It wreaked of desperation.

I'm still holding shares though, and am very patient when it comes to biotech/pharma, so I'm happy to wait 5 more years if needed, on the merit of their other drugs (and somewhat renewed hope with the recent acquisition). I would consider closing my position if they make another bad move like the Coeptis deal though.

[fwb]

Means NOTHING CLDX had a Colab with BMY
and they are in the TANK as well
BMY doesn't take the hit
The Smaller company does